AVIRAtea Pharmaceuticals, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 12099
Ticker: AVIR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-10-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: AVIR

Detail

Enriched 2026-08-14 20:47

Market cap: $404,937,120.94
Shares outstanding (class): 80,027,099
Shares outstanding (weighted): 80,027,099
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 55
Location: BOSTON, MA
Homepage: https://www.ateapharma.com
Description: Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Market cap and share counts drift.

Funds holding this security

76 funds · 76 positions · $45.17M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$12.75M	0.00%	2,369,422 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$9.28M	0.01%	1,724,426 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.35M	0.01%	808,354 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.17M	0.03%	589,863 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$2.48M	0.03%	460,056 NS	FIGI
JPMorgan U.S. Small Company Fund JPMorgan Trust I	—	$1.40M	0.15%	261,130 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.00M	0.00%	186,461 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$948.7K	0.08%	176,334 NS	FIGI
BlackRock Advantage Small Cap Growth Fund BlackRock Funds	—	$768.8K	0.11%	142,903 NS	FIGI
JPMorgan Small Cap Value Fund JPMorgan Trust II	—	$717.6K	0.06%	133,382 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$593.4K	0.48%	110,300 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$569.2K	0.01%	105,808 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$507.6K	0.01%	94,351 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$466.2K	0.03%	86,662 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$378.1K	0.01%	70,280 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERAVIR
FIGI_COMPOSITEBBG00TZNCJ75
FIGI_SHARE_CLASSBBG00TZNCJ84
CIK0001593899
ISINUS04683R1068
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Atea Pharmaceuticals is a biopharmaceutical company focused on antiviral drug development, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.